Autosomal Dominant Congenital Cataracts via the MIP Gene
Summary and Pricing
Test Method
Exome Sequencing with CNV DetectionTest Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
3929 | MIP | 81479 | 81479,81479 | $990 | Order Options and Pricing |
Pricing Comments
Our favored testing approach is exome based NextGen sequencing with CNV analysis. This will allow cost effective reflexing to PGxome or other exome based tests. However, if full gene Sanger sequencing is desired for STAT turnaround time, insurance, or other reasons, please see link below for Test Code, pricing, and turnaround time information.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
The Sanger Sequencing method for this test is NY State approved.
For Sanger Sequencing click here.Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Cataracts are described as opacification of the crystalline lens of the eye that result in abnormal refraction index and light scattering. Congenital cataracts are a leading cause of reversible blindness in childhood. They account for one-tenth of the cases of childhood blindness (Francis and Moore. 2004. PubMed ID: 14743013). Estimated prevalence rate is 1.2 - 6.0 per 10,000 live births. Early diagnosis and surgery and optical correction have resulted in an improved outcome for infants with either unilateral or bilateral cataracts (Lambert and Drack. 1996. PubMed ID: 8724637).
Genetics
Only 10–25% of congenital cataracts are hereditary. Cataracts are most often inherited as an autosomal dominant trait. Cataracts also exhibit autosomal recessive or X-linked inheritance (Hejtmancik. 2008. PubMed ID: 18035564). X-linked cataract is seen in Nance-Horan syndrome (NHS), which is an especially rare disorder. NHS has cataracts along with prominent dental findings, dysmorphic features, and intellectual disability (Toutain et al. 1997. PubMed ID: 9048931; Stambolian et al. 1990. PubMed ID: 1971992). Currently, isolated or primary cataracts have been mapped to about 39 genetic loci, and over 25 of those are connected to pathogenic variants in specific genes. However, this number is constantly increasing (Hejtmancik. 2008. PubMed ID: 18035564).
Pathogenic variants in MIP are causative for autosomal dominant and recessive congenital cataracts, with recessive being the rare form (Gu et al. 2007. PubMed ID: 17893667; Bateman et al. 1986. PubMed ID: 3456204; Bateman et al. 2000. PubMed ID: 10937580). To date, ~25 pathogenic variants have been reported. The majority of the pathogenic variants that cause dominant congenital cataracts are missense variants, although all types of variants have been reported in both the dominant and recessive forms (Yu et al. 2014. PubMed ID: 24405844; Human Gene Mutation Database). There is no specific correlation regarding the genotype and specific forms of cataracts.
MIP encodes lens water channel protein AQP0 (major intrinsic protein), which is an abundant junctional membane protein that controlls the water content for the lens and also as a cell-to-cell adhesion molecule. AQP0 is expressed only in terminally differentiated fiber cells, which are the major cell type of the crystalline lens (Gu et al. 2007. PubMed ID: 17893667; Kumari et al. 2013. PubMed ID: 24120416). Pathogenic missense variants have been reported to impair cell-to-cell adhesion, which plays a vital role in maintaining lens transparency and homeostasis (Kumari et al. 2013. PubMed ID: 24120416).
Clinical Sensitivity - Sequencing with CNV PGxome
In one study, whole exome sequencing identified causative variants in 39% of families affected by cataracts. The genes studied were CRYAA, CRYBB1, CRYBB3, CRYGC, CRYGD, GJA8, and MIP. The MIP gene accounted for only one family (Reis et al. 2013. PubMed ID: 23508780).
Testing Strategy
This test provides full coverage of all coding exons of the MIP gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
All patients with symptoms suggestive of congenital cataracts, including binocular phenotype cataracts, are candidates.
All patients with symptoms suggestive of congenital cataracts, including binocular phenotype cataracts, are candidates.
Gene
Official Gene Symbol | OMIM ID |
---|---|
MIP | 154050 |
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Disease
Name | Inheritance | OMIM ID |
---|---|---|
Cataract 15 | AD | 615274 |
Related Tests
Name |
---|
Congenital Cataracts Panel |
Congenital Cataracts via the CHMP4B Gene |
Citations
- Bateman et al. 1986. PubMed ID: 3456204
- Bateman et al. 2000. PubMed ID: 10937580
- Francis and Moore. 2004. PubMed ID: 14743013
- Gu et al. 2007. PubMed ID: 17893667
- Hejtmancik. 2008. PubMed ID: 18035564
- Human Gene Mutation Database (Bio-base).
- Kumari et al. 2013. PubMed ID: 24120416
- Lambert and Drack. 1996. PubMed ID: 8724637
- Reis et al. 2013. PubMed ID: 23508780
- Stambolian et al. 1990. PubMed ID: 1971992
- Toutain et al. 1997. PubMed ID: 9048931
- Yu et al. 2014. PubMed ID: 24405844
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel
PGnome (Genome) Sequencing Panel
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.